Pluristem (Israel) Today
| PSTI Stock | ILS 1,665 60.00 3.74% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Pluristem is trading at 1665.00 as of the 18th of February 2025, a 3.74 percent up since the beginning of the trading day. The stock's open price was 1605.0. Pluristem has about a 37 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of November 2024 and ending today, the 18th of February 2025. Click here to learn more.
Pluristem Therapeutics Inc., together with its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. Pluristem Therapeutics Inc. was founded in 2001 and is based in Haifa, Israel. PLURISTEM THERAPEU operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. The company has 32.35 M outstanding shares. More on Pluristem
Moving together with Pluristem Stock
Moving against Pluristem Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Pluristem Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pluristem's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pluristem or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Pluristem (PSTI) is traded on Tel Aviv Stock Exchange in Israel and employs 153 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 116.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pluristem's market, we take the total number of its shares issued and multiply it by Pluristem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Pluristem operates under Healthcare sector and is part of Biotechnology industry. The entity has 32.35 M outstanding shares.
Pluristem has accumulated about 10.54 M in cash with (30.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7.
Check Pluristem Probability Of Bankruptcy
Ownership AllocationPluristem owns a total of 32.35 Million outstanding shares. Pluristem holds 7.28 pct. of its outstanding shares held by insiders and 12.8 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Pluristem Ownership Details
Pluristem Risk Profiles
Although Pluristem's alpha and beta are two of the key measurements used to evaluate Pluristem's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.86 | |||
| Standard Deviation | 4.19 | |||
| Variance | 17.59 | |||
| Risk Adjusted Performance | (0.01) |
Pluristem Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pluristem without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Pluristem Corporate Management
Elected by the shareholders, the Pluristem's board of directors comprises two types of representatives: Pluristem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pluristem. The board's role is to monitor Pluristem's management team and ensure that shareholders' interests are well served. Pluristem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pluristem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lior Raviv | Chief Officer | Profile | |
| Nimrod Zvi | Chief Officer | Profile | |
| Efrat LivneHadass | VP HR | Profile | |
| Yaacov Yanay | CEO Pres | Profile | |
| Nitsan MD | Chief Officer | Profile |
Other Information on Investing in Pluristem Stock
Pluristem financial ratios help investors to determine whether Pluristem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pluristem with respect to the benefits of owning Pluristem security.